Viewing Study NCT05552105


Ignite Creation Date: 2025-12-25 @ 3:22 AM
Ignite Modification Date: 2026-05-20 @ 1:55 AM
Study NCT ID: NCT05552105
Status: COMPLETED
Last Update Posted: 2025-03-06
First Post: 2022-09-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Oxylipin Response as a New PrEdictive Biomarker of Patient Responsiveness to Biotherapy in Rheumatoid Arthritis (OPERA)
Sponsor: University Hospital, Clermont-Ferrand
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rheumatoid Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anti TNF View
None Oxylipin View
None Cytokine View
None Polyunsatured fatty acid View